Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma

NCT00303836 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

58

Enrollment

NIH

Sponsor class

Conditions

Recurrent Melanoma
Stage IV Melanoma

Interventions

DRUG: cyclophosphamide
DRUG: fludarabine phosphate
BIOLOGICAL: therapeutic autologous lymphocytes
PROCEDURE: in vitro-treated peripheral blood stem cell transplantation
BIOLOGICAL: gp100 antigen
BIOLOGICAL: MART-1 antigen
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: filgrastim
BIOLOGICAL: aldesleukin

Sponsor

National Cancer Institute (NCI)